IFNγ plays a pivotal role in tumor immunosurveillance and cancer immunotherapy by increasing MHC expression, promoting antigen presentation, directly inhibiting tumor cell proliferation, and augmenting tumor‐infiltrating immune cells’ functions.[21] Collectively, these results confirmed that short peptide FK‐13 could activate both innate and adaptive immunity. This evidence concerns the gene IFNG and neoplasm.